Getinge AB (FRA:GTN) Common Stock : €12 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Getinge AB Common Stock?

Getinge AB's quarterly common stock declined from Jun. 2024 (€12 Mil) to Sep. 2024 (€0 Mil) but then increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€12 Mil).

Getinge AB's annual common stock declined from Dec. 2022 (€12 Mil) to Dec. 2023 (€12 Mil) and declined from Dec. 2023 (€12 Mil) to Dec. 2024 (€12 Mil).

Getinge AB Common Stock Historical Data

The historical data trend for Getinge AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB Common Stock Chart

Getinge AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

13.37

13.24

12.37

12.16

11.82

Getinge AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															12.16	12.02	12.05	-	11.82

Getinge AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Getinge AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (FRA:GTN) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

GNGBY:USA GNGBF:USA GETI B:Sweden GETIBs:UK 0GZV:UK GTN:Germany

Address

Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56

Website

https://www.getinge.com

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.